Research
We invite novel laboratory research proposals and clinical investigations pertaining to cancer affecting women in areas such as:
- Tumor Biology
- Novel Molecular Targets
- Companion Diagnostics
- Improvement in Quality of Life
- Hereditary Cancer Genetics
Science Advisors
The Lewin Fund’s scientific advisors are world-renowned leaders in women’s cancer research. They review proposals consistent with the mission and priorities of The Lewin Fund.
Alyson Moadel-Robblee, PHD
Professor
Department of Epidemiology & Population Health
Division of Health Promotion and Nutrition Research
Department of Medicine, Division of Oncology
Director, Psychosocial Oncology/BOLD Program
Albert Einstein Cancer Center
Bronx, NY
Jennifer Klemp, PHD, MPH, MA
Founder/CEO, Cancer Survivorship Training, Inc.
Associate Professor of Medicine, Division of Clinical Oncology
Director, Cancer Survivorship
Cancer Risk and Genetic Counseling
University of Kansas Cancer Center
Kansas City, KS
Rami Eitan, MD
Department of Obstetrics and Gynecology
Faculty of Medicine
Sackler School of Medicine
Tel Aviv University
Ramat Aviv, Israel
Robert L. Coleman, MD
Professor, Department of Gynecologic Oncology and Reproductive Medicine; Vice Chair, Clinical Research
Ann Rife Cox Chair in Gynecology
The University of Texas
MD Anderson Cancer Center
Houston, TX
Christopher S. Awtrey, MD
Assistant Professor, Obstetrics and Gynecology
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, MA
Nadeem Abu-Rustum, MD
Chief Gynecology Service
Professor, Weill Cornell Medical College
Vice Chair Technology, Department of Surgery Memorial Sloan-Kettering Cancer Center
New York, NY
